Led · Series A · Jul 2026

Founded in 2024 and based in Berlin, dsb offers certified energy consulting where consultants collect building data to create a digital twin and an individual renovation roadmap (iSFP). The company reviews and handles subsidy applications through KfW and BAFA and coordinates implementation of measures such as solar panels, heat pumps, window replacement, and insulation via a network of vetted trades businesses. dsb says its process reduces the homeowner's time requirement by approximately 80%. Since founding it has tripled in size and now serves over 10,000 private customers and works with around 300 local skilled trades businesses. The company forecasts revenue exceeding €15 million for 2026. Planned product and go-to-market moves include launching a proprietary electricity tariff and expanding into the B2B market.

Participated · Series A · May 2026

Pacifico Biolabs develops protein ingredients using mycelium fermentation technology and produces them in standard beer brewery fermentation tanks rather than purpose-built bioreactors. By repurposing existing brewery infrastructure the company seeks to lower production costs and scale more quickly using underutilised fermentation capacity. Pacifico positions its product as a domestically produced protein alternative to imported feed protein, aiming to shorten supply chains and reduce environmental and geopolitical exposure. The company plans to scale production in Saxony, Germany, expand its team, and roll out commercial launches across the DACH region and Nordic Europe, targeting retail launches by late 2026. The recent €7 million Series A will fund those near-term expansion and commercialization efforts.

Led · Series A · Apr 2026

VisioLab offers an AI that recognizes food and beverages via camera—without barcodes or specialized hardware—and runs as an app on a standard Apple iPad paired with a compact Bluetooth payment terminal. The system identifies products within seconds, displays prices, and enables payment, with the company saying the full setup can be operational in under five minutes. VisioLab reports it processes around one million transactions per month and operates 43 systems in the Orlando Magic arena, covering nearly the entire stadium per the company. Its U.S. sports customers include NFL teams Atlanta Falcons and Carolina Panthers and MLS club Inter Miami, and it partners with global caterers Compass Group and Aramark. In Germany, roughly one in three university campuses uses the technology through student services, and the system is deployed in staff restaurants at DAX-listed corporations and companies in banking, insurance, and automotive sectors. The company plans to expand internationally and increase headcount to support growth in sports, corporate, and campus segments.

Participated · Equity · Mar 2026

Eternal.ag designs and builds autonomous robots for greenhouse harvesting, with its first commercial product—Harvester—targeting tomato greenhouses. Harvester is a modular, AI-powered robot that can operate up to 22 hours a day and feeds data back into the system to improve performance. The company uses a simulation-first development approach to train and validate robots in virtual greenhouses, shortening iteration cycles. Eternal.ag envisions fully automated greenhouse operations by 2040 and plans to expand its platform with additional robotic functions for broader greenhouse tasks. Founded by Renji John and Sherry Kunjachan, the company has 26 employees and is headquartered in Cologne with an office in Bengaluru. Following the announced €8 million funding round, Eternal.ag intends to accelerate product development and expand commercial deployments across Europe while extending into additional crop types.

Participated · Seed · Jan 2026

SenseUP is a Cologne-based ag-biotech startup creating double-stranded RNA (dsRNA) biopesticides that selectively disable pests via RNA interference while sparing soil, plants, and wildlife. Its key innovation is engineering Corynebacterium strains that both encapsulate dsRNA inside robust cell walls and produce it at high titers, giving the products 18-plus months of room-temperature stability and production costs that can compete with synthetic chemicals. Proprietary fluorescence-activated biosensors screen millions of strains per second, allowing rapid identification of top dsRNA producers and enabling single products that can target multiple pests simultaneously. The company has completed initial field trials and is now advancing roughly 15 product candidates, with greenhouse and expanded field results expected in 2026. SenseUP plans to submit regulatory dossiers and commercialize through partnerships with major agricultural firms, initially focusing on the U.S. and South American markets while also eyeing Europe. The seed financing provides capital to expand its portfolio, grow its team, and deepen strategic collaborations. No revenue figures have been disclosed, and this seed raise represents the first publicly reported external funding for the company.